Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-119713
Filing Date
2024-11-15
Accepted
2024-11-15 16:12:38
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B5 tm2426602-2_424b5.htm 424B5 701926
2 EX-FILING FEES tm2426602d2_ex-filingfees.htm   iXBRL EX-FILING FEES 28873
3 GRAPHIC lg_gilead-4c.jpg GRAPHIC 12157
  Complete submission text file 0001104659-24-119713.txt   894911

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2426602d2_ex-filingfees_htm.xml XML 9084
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-273745 | Film No.: 241467974
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)